Motoi Uchino, Hiroki Ikeuchi, Toshihiro Bando, Teruhiro Chohno, Hirofumi Sasaki, Yuki Horio, Ryuichi Kuwahara, Tomohiro Minagawa, Yoshiko Goto, Kaoru Ichiki, Kazuhiko Nakajima, Yoshiko Takahashi, Takashi Ueda, Yoshio Takesue
PURPOSE: It is unclear whether immunomodulators or biologics, with the exception of corticosteroids, can be risk factors for postoperative infectious complications of ulcerative colitis (UC). Moreover, many immunosuppressive therapies including some biologics are used mainly to treat UC, and many patients are on multi-agent immunosuppressive therapy at the time of surgery. Therefore, we evaluated the influence of pre-operative multiple immunosuppressive agents on the occurrence of surgical site infection (SSI) in UC during the era of biologics...
January 26, 2019: International Journal of Colorectal Disease